Foley Hoag Advises Good Start Genetics, Inc. in Collaboration Agreement with PerkinElmer, Inc.

April 10, 2014

Foley Hoag partners Alex Aber and Hemmie Chang recently advised Good Start Genetics®, Inc., an innovative molecular genetic information company, in the negotiation of a strategic agreement with PerkinElmer, Inc. (NYSE:PKI) to expand access to GoodStart Select™ genetic carrier screening tests beyond the in vitro fertilization (IVF) setting to the broader women’s health community, including obstetrics and gynecology (OBGYN) and maternal fetal medicine (MFM) physicians.

“Under the terms of the collaboration agreement, PerkinElmer will serve as the exclusive commercial partner of Good Start Genetics in the sales and marketing of GoodStart Select to targeted OBGYN and MFM physicians in the United States,” Hemmie Chang noted.

“We are excited about our collaboration with PerkinElmer – it expands access to the GoodStart Select tests to ordering physicians that are not within Good Start Genetics’ current commercial market of in vitro fertilization and broadens PerkinElmer’s extensive prenatal screening menu to include the highly-validated genetic carrier screening tests included in the GoodStart Select menu,” said Don Hardison, president and chief executive officer of Good Start Genetics. “Alex and Hemmie were important members of the team – they understand our business objectives and they delivered timely and valuable advice from start to finish.”

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and investment management fields, and in cross-border disputes. Our professionals  possess the skills  and experience to provide exceptional senior level service to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.